VFA
CDMO

Valeo Financial Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Valeo Financial Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,265
Closed -$126K – 2201
2020
Q2 		$126K Buy
19,265
+8,289
+76% +$46.3K 0.01% 436
2020
Q1 		$52K Sell
10,976
-8,761
-44% -$53K 0.01% 599
2019
Q4 		$151K Hold
19,737
– – 0.01% 374
2019
Q3 		$105K Hold
19,737
– – 0.01% 423
2019
Q2 		$111K Buy
19,737
+13,913
+239% +$57.4K 0.01% 407
2019
Q1 		$25K Buy
+5,824
New +$23.8K ﹤0.01% 718

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Valeo Financial Advisors's CDMO Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2020, closing a stake of 19,265 shares — an estimated $126K sold.

Valeo Financial Advisors first reported a position in CDMO in Q1 2019 and held it in 6 quarters. The position peaked at $151K in Q4 2019. 111 funds tracked by Wall St. Rank hold CDMO as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 19,265 Avid Bioservices, Inc. Common Stock shares in Q3 2020, an estimated $126K.
  • Valeo Financial Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • Valeo Financial Advisors's Avid Bioservices, Inc. Common Stock position peaked at $151K in Q4 2019.
  • 111 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.